Differentiation between Radiation Necrosis and Tumor Progression Using Chemical Exchange Saturation Transfer

被引:126
作者
Mehrabian, Hatef [1 ,2 ]
Desmond, Kimberly L. [2 ]
Soliman, Hany [3 ,4 ]
Sahgal, Arjun [2 ,3 ,4 ]
Stanisz, Greg J. [1 ,2 ,5 ]
机构
[1] Univ Toronto, Med Biophys, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Phys Sci, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Radiat Oncol, Toronto, ON, Canada
[4] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[5] Med Univ Lublin, Dept Neurosurg & Pediat Neurosurg, Lublin, Poland
关键词
KNIFE STEREOTACTIC RADIOSURGERY; HIGH-GRADE GLIOMAS; BRAIN METASTASES; WATER SATURATION; RECURRENT TUMOR; PERFUSION MRI; TRANSFER CEST; CONTRAST; PEPTIDES; PROTEINS;
D O I
10.1158/1078-0432.CCR-16-2265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Stereotactic radiosurgery (SRS) is a common treatment used in patients with brain metastases and is associated with high rates of local control, however, at the risk of radiation necrosis. It is difficult to differentiate radiation necrosis from tumor progression using conventional MRI, making it a major diagnostic dilemma for practitioners. This prospective study investigated whether chemical exchange saturation transfer (CEST) was able to differentiate these two conditions. Experimental Design: Sixteen patients with brain metastases who had been previously treated with SRS were included. Average time between SRS and evaluation was 12.6 months. Lesion type was determined by pathology in 9 patients and the other 7 were clinically followed. CEST imaging was performed on a 3T Philips scanner and the following CEST metrics were measured: amide proton transfer (APT), magnetization transfer (MT), magnetization transfer ratio (MTR), and area under the curve for CEST peaks corresponding to amide and nuclear Overhauser effect (NOE). Results: Five lesions were classified as progressing tumor and 11 were classified as radiation necrosis (using histopathologic confirmation and radiographic follow-up). The best separation was obtained by NOEMTR (NOEMTR, necrosis = 8.9 +/- 0.9%, NOEMTR, progression = 12.6 +/- 1.6%, P < 0.0001) and Amide(MTR) (Amide(MTR, necrosis) = 8.2 +/- 1.0%, Amide(MTR, progression) = 12.0 +/- 1.9%, P < 0.0001). MT (MTnecrosis = 4.7 +/- 1.0%, MTprogression = 6.7 +/- 1.7%, P = 0.009) and NOEAUC (NOEAUC, necrosis = 4.3 +/- 2.0% Hz, NOEAUC, progression = 7.2 +/- 1.9% Hz, P = 0.019) provided statistically significant separation but with higher P values. Conclusions: CEST was capable of differentiating radiation necrosis from tumor progression in brain metastases. Both NOEMTR and Amide(MTR) provided statistically significant separation of the two cohorts. However, APT was unable to differentiate the two groups. (C) 2017 AACR.
引用
收藏
页码:3667 / 3675
页数:9
相关论文
共 48 条
[1]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[2]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[3]   A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy [J].
Ayala-Peacock, Diandra N. ;
Peiffer, Ann M. ;
Lucas, John T. ;
Isom, Scott ;
Kuremsky, J. Griff ;
Urbanic, James J. ;
Bourland, J. Daniel ;
Laxton, Adrian W. ;
Tatter, Stephen B. ;
Shaw, Edward G. ;
Chan, Michael D. .
NEURO-ONCOLOGY, 2014, 16 (09) :1283-1288
[4]   Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging [J].
Barajas, R. F. ;
Chang, J. S. ;
Sneed, P. K. ;
Segal, M. R. ;
McDermott, M. W. ;
Cha, S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (02) :367-372
[5]   Lipid droplets in inflammation and cancer [J].
Bozza, Patricia T. ;
Viola, Joao P. B. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2010, 82 (4-6) :243-250
[6]   Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis [J].
Chao, Samuel T. ;
Ahluwalia, Manmeet S. ;
Barnett, Gene H. ;
Stevens, Glen H. J. ;
Murphy, Erin S. ;
Stockham, Abigail L. ;
Shiue, Kevin ;
Suh, John H. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (03) :449-457
[7]  
Chavez S., 2012, P INT SOC MAG RESON, P2389
[8]  
Chavez S., 2015, P INT SOC MAG RESON, P1673
[9]   A novel method for simultaneous 3D B1 and T1 mapping: the method of slopes (MoS) [J].
Chavez, Sofia ;
Stanisz, Greg J. .
NMR IN BIOMEDICINE, 2012, 25 (09) :1043-1055
[10]   CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC-PATHOLOGICAL STUDY [J].
Dequesada, Ivan M. ;
Quisling, Ronald G. ;
Yachnis, Anthony ;
Friedman, William A. .
NEUROSURGERY, 2008, 63 (05) :898-903